News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • EVT yields 7.04% at $28.07.
  • The fund's P/E is 4.4, indicating a low valuation.
  • Price-to-book sits near 1.
  • Market is divided between income buyers and short sellers.
  • Analysts recommend EVT as a buy for income investors seeking yield and potential price re-rating.
  • Closed-end fund structure raises distribution and liquidity risk.

Latest Articles

Lakeland Financial Reports Record Second Quarter Performance; Net Income Increases 5% to $28.4 million on 7% Revenue Expansion; Average Loans Grow by 6%

Lakeland Financial Reports Record Second Quarter Performance; Net Income Increases 5% to $28.4 million on 7% Revenue Expansion; Average Loans Grow by 6%

Lakeland Financial Corporation reported a record second quarter 2026 net income of $28.4 million, a 5% increase year-over-year, driven by 7% growth in total revenue and 6% growth in average loans. The company maintained a stable net interest margin of 3.49%, improved capital ratios, expanded its loan portfolio across commercial and consumer segment…

Picard Medical Receives NYSE American Acceptance of Compliance Plan

Picard Medical Receives NYSE American Acceptance of Compliance Plan

Picard Medical, the only US-based maker of the FDA-approved total artificial heart, announced NYSE American has accepted its compliance plan to meet listing standards, allowing the company to continue trading under ticker PMI. The company is focusing on operational, strategic, and financial initiatives, including advancing its next-generation Emper…

VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb

VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb

VERAXA Biotech announced successful progression of its bispecific ADC program VXA-222 following a key milestone achieved in its collaboration with OmniAb. This program utilizes an AND-gate logic to target two antigens on solid tumors and has now moved into the next phase, combining OmniAb’s antibody discovery technology with VERAXA’s conjugation an…

OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026

OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026

OKYO Pharma Limited, a clinical-stage biopharmaceutical company focused on neuropathic corneal pain and anterior segment eye diseases, announced its participation in the BTIG Biotechnology Conference 2026. Management will present virtually and offer one-on-one meetings. The company plans to initiate a global Phase 3 pivotal trial in H2 2026 for its…

Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026

Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026

Neumora Therapeutics announced positive results from a repeat 13-week toxicology study for its oral NLRP3 inhibitor NMRA-215, intended to treat obesity and cardiometabolic disease. Following the favorable safety profile and efficacy data, the company plans to submit an IND application and initiate clinical trials for NMRA-215 in late 2026. The drug…

MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia

MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia

MapLight Therapeutics announced positive topline results from its Phase 2 ZEPHYR trial evaluating ML-007C-MA in adults with schizophrenia. The 210/3 mg BID dose met the primary endpoint with statistically significant improvement in PANSS total score and notable cognitive performance enhancements. The treatment was well tolerated with a favorable sa…

Expand Energy Corporation to Acquire Twin Eagle, Creating North America’s Leading Integrated Natural Gas Company

Expand Energy Corporation to Acquire Twin Eagle, Creating North America’s Leading Integrated Natural Gas Company

Expand Energy Corporation announced a definitive merger agreement to acquire Twin Eagle Holdings for $1.25 billion, combining Expand's production leadership with Twin Eagle's asset-backed natural gas marketing platform. The deal is expected to close in Q3 2026, immediately accretive, initially contributing over $200 million in annual EBITDA with $1…

XPO Appoints Michael Kneeland to Board of Directors

XPO Appoints Michael Kneeland to Board of Directors

XPO, a leading North American freight transportation company, announces the appointment of Michael Kneeland to its board of directors. Kneeland brings extensive experience from his leadership roles at United Rentals and Gildan Activewear, adding valuable expertise to XPO's governance and strategic direction.

Diana Shipping Inc. Urges Genco Shipping & Trading to Stop Misleading Investors and Engage in Good Faith Negotiations

Diana Shipping Inc. Urges Genco Shipping & Trading to Stop Misleading Investors and Engage in Good Faith Negotiations

Diana Shipping Inc. announced the expiration and termination of its tender offer to acquire the outstanding shares of Genco Shipping & Trading Limited, citing a lack of substantive engagement from Genco's board. Despite offering a 53% premium over Genco's price before the initial proposal, Diana accuses Genco's board of misleading investors and sta…

Wetour Robotics to Enter into Warehouse Robotics Cooperation Agreement; Management Estimates Full Contemplated Rollout Could Generate Approximately US$5.0 Million in Project-Level Gross Profit

Wetour Robotics to Enter into Warehouse Robotics Cooperation Agreement; Management Estimates Full Contemplated Rollout Could Generate Approximately US$5.0 Million in Project-Level Gross Profit

Wetour Robotics Limited announced its U.S. subsidiary is seeking a cooperation agreement with a warehouse automation robotics company to support its multi-site Orchestra commercial project implementation. Management estimates the full project rollout could generate approximately $5 million in project-level gross profit, though the cooperation agree…

CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder

CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder

CAMP4 Therapeutics announced that it has received regulatory clearance from Australia's Therapeutic Goods Administration and Human Research Ethics Committee to commence the first-in-human clinical trial of CMP-002, a novel therapeutic targeting SYNGAP1-related disorder. This milestone triggers eligibility to raise up to $50 million in additional fu…

Fury Resumes Activities at Eau Claire

Fury Resumes Activities at Eau Claire

Fury Gold Mines Limited has resumed its exploration and drilling activities at the Eau Claire gold project in Northern Quebec after a precautionary suspension caused by a nearby wildfire. All personnel have returned safely, and the company confirms no material impact on its Phase 2 drilling program. Fury continues to prioritize safety and maintains…

Akita Drilling: Capacity Expansion Sets Up A Re-rate Opportunity

Akita Drilling: Capacity Expansion Sets Up A Re-rate Opportunity

AKITA Drilling completed a major capacity expansion and is trading at a $142M market cap near $2.55. With utilization likely to rise, technical momentum turning constructive, and outsized short activity creating a squeeze vector, a disciplined long trade targeting $4.25 over a 180 trading day horizon offers a favorable risk/reward. Manage position …

SPX Announces Appointment of New Board Member

SPX Announces Appointment of New Board Member

SPX Technologies has appointed Brian Deck as a new independent member of its Board of Directors, effective July 27, 2026. Mr. Deck will also join the Audit and Governance & Sustainability Committees. Bringing extensive experience from his current role as CEO of JBT Marel Corporation and former leadership roles in finance and operations, his additio…